---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-423002"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2026-10-15T21:00:14+00:00"
generated_at: "2026-10-15T21:02:12.496953+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Olema director Gorjan Hrustanovic resigns; Prakash Raman named to two board committees

## Summary
- Dr. Gorjan Hrustanovic notified Olema on October 12, 2026 of his resignation from the Board of Directors, effective October 14, 2026.
- Hrustanovic also resigned from the Board's Compensation Committee and Science and Technology Committee; the filing states no disagreement with the company prompted the exit.
- On October 15, 2026, the Board appointed Dr. Prakash Raman to the Compensation Committee and the Science and Technology Committee, effective the same day.
- No permanent replacement for Hrustanovic's full board seat was disclosed in the filing; Sean Bohen, M.D., Ph.D., remains President and CEO.
- Committee reshuffle only — no financial terms, equity awards or severance arrangements were described.

## SEC filing metadata
- accession: 0001193125-26-423002
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2026-10-15T21:00:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/0001193125-26-423002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/olma-20261012.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-423002
- JSON: https://secwatch.observer/filing/0001193125-26-423002.json
- Plain text: https://secwatch.observer/filing/0001193125-26-423002.txt

## Key facts
- Executive change
  Gorjan Hrustanovic resigned as Director at Olema Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Director
  source text: On October 12, 2026, Dr. Gorjan Hrustanovic notified Olema Pharmaceuticals, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), effective October 14, 2026. Dr. Hrustanovic also resigned from the Compensation Committee of the Board (the “Compensation Committee”) and the Science and Technology Committee of the Board (the “Science and Technology Committee”). Dr. Hrustanovic’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/0001193125-26-423002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.